Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease

Emerging Infectious Diseases

Volumn 5, Issue 6, 1999, Pages 828-831

  Fiore, Anthony E ^a,b   Levine, Orin S ^a   Elliott, John A ^a   Facklam, Richard R ^a   Butler, Jay C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE;

ARTICLE; BACTERIUM ISOLATE; CHRONIC DISEASE; DRUG EFFICACY; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0033396326     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0506.990616     Document Type: Article

References (23)

1. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(RR-8).
2. Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 1995;33:2759-62.
3. American Academy of Pediatrics. Pneumococcal infections. In: Peter G, editor. 1997 Red book: report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village (IL): American Academy of Pediatrics; 1997. p. 410-9.
4. Riley ID, Everingham FA, Smith DE, Douglas RM. Immunisation with a polyvalent pneumococcal vaccine: Effect on respiratory mortality in children living in the New Guinea highlands. Arch Dis Child 1981;56:354-7.
5. Rosén C, Christensen P, Hovelius B, Prellner K. Effect of pneumococcal vaccination on upper respiratory tract infections in children: Design of a follow-up study. Scand J Infect Dis 1983;Suppl 39:39-44.
6. Douglas RM, Miles HB. Vaccination against Streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children. J Infect Dis 1984;149:861-9.
7. Ammann AJ, Addiego J, Wara DW, Lubin B, Smith WB, Mentzer WC. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. N Engl J Med 1977;297:897-900.
8. Ahonkhai VI, Landesman SH, Fikrig SM, Smalzer EA, Brown AK, Cherubin CE, et al. Failure of pneumococcal vaccine in children with sickle-cell disease. N Engl J Med 1979;301:26-7.
9. John AB, Ramlal A, Jackson H, Maude GH, Waight-Sharma, A, Serjeant GR. Prevention of pneumococcal infection in children with homozygous sickle cell disease. BMJ 1984;288:1567-70.
10. Broome CV, Facklam RR, Fraser DW. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 1980;549-52.
11. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal vaccine efficacy: an evaluation of current recommendations. JAMA 1993;270:1826-31.
12. Broome CV. Efficacy of pneumococcal polysaccharide vaccines. Rev Infect Dis 1981;Suppl 3:S82-8.
13. Black SB, Shinefield H, Ray P, Lewis E, Fireman P, et al. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: results of the Northern California Kaiser Permanente Efficacy Trial. In: Programs and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1998; San Diego, California. Washington: American Society for Microbiology, 1998.
14. Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, Margolis A, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453-60.
15. Sims RV, Steinmann WC, McConville JH, King LR, Zwick WC, Schwartz JS. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med 1988;108:653-7.
16. Fair BM, Johnston BL, Cobb JK, Fisch MJ, Germanson TP, Adal KA, et al. Preventing pneumococcal bacteremia in patients at risk: Results of a matched case-control study. Arch Intern Med 1995;155:2336-40.
17. Gable CB, Holzer SS, Engelhart L, Friedman RB, Smeltz F, Schroeder D, et al. Pneumococcal vaccine: efficacy and associated cost savings. JAMA 1990;264:2910-5.
18. Sisk JE, Moskowitz AJ, Whang W, Lin JD, Fedson DS, McBean AM, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 1997;278;1333-9.
19. Copeland KT, Checkoway H, Holbrook RH, McMichael AJ. Bias due to misclassification in the estimate of relative risk. Am J Epidemiol 1977;105:488-95.
20. Kayhty H, Åhman H, Ronnberg P-R, Tillikainen R, Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis 1995;172:1273-8.
21. 197 in United States infants. Paediatrics 1998;101:604-11.
22. Ahman H, Kayhty H, Lehtonen H, Leroy O, Froeschle J, Eskola J. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to produce immunologic memory. Pediatr Infect Dis J 1998;17:211-6.
23. Obaro SK, Huo Z, Banya WAS, Henderson DC, Monteil MA, Leach A, et al. A glycoprotein conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children. Pediatr Infect Dis J 1997;16:1135-40.